Frazis Capital Podcast
#92: Syntara Phase 2 Success, Geopolitics and Uranium
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:25:06
- Mais informações
Informações:
Sinopse
Syntara’s highly anticipated Phase 2 results in myelofibrosis—what the data tells us, why the market sold off, and what might come next in terms of funding or partnership.
